EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Dividend Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
The Management Board of Fresenius Management SE decided today that Fresenius Group will retain the governmental compensation and reimbursement payments of up to €300 million (from the current perspective) for German hospitals provided for in the "Energy Relief Package" (Entlastungspaket Energiehilfen). The retention of these payments, which Fresenius will use to promote the long-term strengthening of the Company, is subject to legal restrictions. Among other things, Fresenius SE & Co. KGaA is prohibited by law from paying a dividend to its shareholders for the financial year 2023. Furthermore, no bonuses or other variable compensation components for the financial year 2023 may be paid to the members of the Management Board of Fresenius Management SE and the management bodies of other companies covered by the statutory bans. Today's resolution of the Management Board is subject to the approval of the Supervisory Board of Fresenius Management SE, which is expected to decide on this approval on 6 December 2023. Also on 6 December 2023, the Supervisory Board of Fresenius SE & Co. KGaA is expected to decide on the favorable acknowledgement of today's resolution of the Management Board. The cash inflow of compensation and reimbursement payments as well as the dividend suspension will reduce the company's debt and consequently improve the leverage ratio by around 20 to 25 basis points. The reduction in debt will have a positive effect on net interest expense and ultimately on earnings per share. For additional information on the performance indicators used please refer to our website at https://www.fresenius.com/alternative-performance-measures. (Financial statements according to IFRS) Fresenius SE & Co. KGaA, represented by Fresenius Management SE, The Management Board Bad Homburg v.d.H., December 5, 2023 ---------------------------------------- Contact: Markus Georgi Senior Vice President Investor Relations T: +49 (0) 6172 608-2485 markus.georgi@fresenius.com ---------------------------------------- End of Note End of Inside Information
05-Dec-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Fresenius SE & Co. KGaA |
Else-Kröner-Straße 1 | |
61352 Bad Homburg v.d.H. | |
Germany | |
Phone: | +49 (0)6172 608-2485 |
Fax: | +49 (0)6172 608-2488 |
E-mail: | ir-fre@fresenius.com |
Internet: | www.fresenius.com |
ISIN: | DE0005785604 |
WKN: | 578560 |
Indices: | DAX |
Listed: | Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange |
EQS News ID: | 1790001 |
End of Announcement | EQS News Service |
|
1790001 05-Dec-2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.